<DOC>
	<DOC>NCT00433654</DOC>
	<brief_summary>The purpose of this clinical study is to confirm safety and efficacy in the clinical magnetic resonance imaging (MRI) environment of the investigational EnRhythm MRI™ SureScan™ Pacing System (used in support of Revo MRI™ SureScan Pacing System launch).</brief_summary>
	<brief_title>EMRI SureScan™ Clinical Study</brief_title>
	<detailed_description>This study is a prospective, multi-center global study.</detailed_description>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Subject has, or is at risk of having, a heart beat that is too slow and his/her doctor has determined he/she needs a pacemaker. Subject available for followup at study center for length of study. Subject able and willing to undergo elective MRI scanning without sedation. Subject has, or is at risk of having, a heart beat that is too fast and his/her doctor has determined he/she needs an implantable cardioverter defibrillator (ICD). Subject needs or will need another MRIscan, other than those required by the study, during the required study followup period. Pregnant women, or women of child bearing potential who are not on a reliable form of birth control. Subject with exclusion criteria required by local law. Subject who intends to participate in another clinical study during this clinical study.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Bradycardia</keyword>
	<keyword>Slow heart beat</keyword>
	<keyword>Magnetic resonance imaging (MRI)</keyword>
</DOC>